Skip to content
TrialMatch
Sign up
Recruiting

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Create a profile to match View the full record on ClinicalTrials.gov

About this study

The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.

Condition
Melanoma Stage III, B-cell Non Hodgkin Lymphoma, Pediatric ALL, Childhood Non-Hodgkin Lymphoma, Acute Lymphatic Leukemia, Chronic Lymphatic Leukemia, Melanoma Stage IV
Tested
MB-CART19.1, MB-CART20.1, MB-CART2019.1
Sponsor
Miltenyi Biomedicine GmbH

Who can join

Age
Not specified
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 3

  • Study condition: Melanoma Stage III, B-cell Non Hodgkin Lymphoma, Pediatric ALL, Childhood Non-Hodgkin Lymphoma, Acute Lymphatic Leukemia, Chronic Lymphatic Leukemia, Melanoma Stage IV
  • Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.
  • Patient has provided informed consent prior to enrollment.

Exclusion 1

  • No exclusion criteria

Where

7 sites, 2 recruiting

Charité Universitätsmedizin Berlin

Berlin, Germany

Recruiting

Universitätsklinikum Münster

Münster, Germany

Recruiting

Universitätsklinikum Köln

Cologne, Germany

Uniklinikum Erlangen

Erlangen, Germany

Universitätsmedizin Göttingen

Göttingen, Germany

Universitätsklinikum Tübingen

Tübingen, Germany

and 1 more site on ClinicalTrials.gov

Contact

Potential match only. Final eligibility is determined by the study team.